Phio Pharmaceuticals Corp. (PHIO) Dividend History

Phio Pharmaceuticals Corp. (PHIO) is a biotechnology company that focuses on developing immuno-oncology therapies using its proprietary RNA interference (RNAi) platform. The company aims to enhance the body's immune response to cancer by targeting and modulating specific genes involved in tumor immune evasion.

11 Apex Drive, Suite 300a, Marlborough, MA, 01752
Phone: (508) 767-3861
Website: https://www.phiopharma.com

Dividend History

Phio Pharmaceuticals Corp. currently does not pay dividends

Company News

  • Retinoblastoma Treatment Market to Surpass $2 Billion in 2024, Exhibiting a CAGR of 5.5% - Global Long-term Forecasts to 2028 and 2033

    The global retinoblastoma treatment market is projected to grow from $1.93 billion in 2023 to $2.03 billion in 2024, driven by factors like increased funding, cancer research, and technological advancements. The market is expected to reach $2.56 billion by 2028, growing at a CAGR of 5.9%.

    GlobeNewswire Inc.
    Featured Companies: BAX BMY JNJ LLY MRK PFE RCUS REGN
  • Why Nxu Shares Are Trading Higher By Around 42%; Here Are 20 Stocks Moving Premarket

    Shares of Nxu, Inc. (NASDAQ: NXU) rose sharply in pre-market trading after the company signed a letter of intent outlining investment in Lynx Motors. Nxu, shares rose 42.1% to $0.0278 in pre-market trading. Here are some other stocks moving in pre-market trading. Gainers XBP Europe Holdings, Inc. (NASDAQ: XBP) shares rose 150% to $14.20 in pre-market trading after declining around 20% on Wednesday. Hanryu Holdings, Inc. (NASDAQ: HRYU) gained 34.8% to $1.47 in pre-market trading after jumping 28% on Wednesday. Meiwu Technology Company Limited (NASDAQ: WNW) shares gained 21.1% to $0.0850 in pre-market trading. Codexis, Inc. (NASDAQ: CDXS) shares surged 20.5% to $2.52 in pre-market trading. Codexis announced achievement of gram-scale synthesis with its ECO Synthesis platform. Esperion Therapeutics, Inc. (NASDAQ: ESPR) shares climbed 15.2% to $1.74 in pre-market trading. Esperion said that the FDA updated LDL-C lowering indication for NEXLETOL (bempedoic acid) tablet and NEXLIZET (bempedoic acid and ezetimibe) tablet. Blue Water Biotech, Inc. (NASDAQ: BWV) shares rose 14.9% to $0.3109 in pre-market trading after gaining ...

    Benzinga
    Featured Companies: ADBE ASYS CDXS EKSO ESPR INTS OCUL RGS SNOA STTK WNW XBP
  • Penny Stocks To Buy Now? 5 Under $5 To Watch This Week

    Penny stocks to buy? Here are some of the most active under $5 to watch. The post Penny Stocks To Buy Now? 5 Under $5 To Watch This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    PennyStocks
    Featured Companies: ACRS ARDX RENT
  • PHIO Jumps 91% on Encouraging Preclinical Cancer Drug Data

    Data from preclinical studies show that Phio's (PHIO) cancer drug PH-894 is effective in BRD4 inhibition for treating various cancer indications like melanoma, breast cancer and lung cancer.

    Zacks Investment Research
    Featured Companies: ALLO ANVS CORT
Page data last updated 07/23/2025 12:08:49 UTC